Decreased expression of MT1E is a potential biomarker of prostate cancer progression-Reference-Cited by-同舟云学术

Decreased expression of MT1E is a potential biomarker of prostate cancer progression

Published:2017-06-27 Issue:37 Volume:8 Page:61709-61718
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Demidenko Rita¹,Daniunaite Kristina¹²,Bakavicius Arnas²³,Sabaliauskaite Rasa²,Skeberdyte Aiste¹²,Petroska Donatas⁴,Laurinavicius Arvydas⁴⁵,Jankevicius Feliksas²⁵,Lazutka Juozas R.¹,Jarmalaite Sonata¹²

Affiliation:

1. Life Sciences Centre, Vilnius University, Vilnius, Lithuania

2. National Cancer Institute, Vilnius, Lithuania

3. Urology Centre, Vilnius University, Vilnius, Lithuania

4. National Centre of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania

5. Faculty of Medicine, Vilnius University, Vilnius, Lithuania

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and genetic analysis of a case of a patient with familial hereditary breast cancer: a case report;Journal of Medical Case Reports;2024-08-14

2. Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma;Scientific Reports;2024-07-01

3. MT1E in AML: a gateway to understanding regulatory cell death and immunotherapeutic responses;Journal of Leukocyte Biology;2024-06-29

4. NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8;Advanced Science;2024-06-23

5. Predicting prostate cancer recurrence: Introducing PCRPS, an advanced online web server;Heliyon;2024-04